The tragedy of mitotic catastrophe in podocytes
Kidney International · 2024-06 · 105 (6) · 1153-1156
DOI: 10.1016/j.kint.2024.01.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney International, 2024-06. Verfasst von Stuart J Shankland und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, University of Washington, Seattle, Washington, USA; Institute for Stem Cell & Regenerative Medicine, University of Washington…. Hauptthemen laut MEDLINE: Podocytes, Mitosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 9 Literaturangaben. Gefördert von: NIDDK NIH HHS, National Institutes of Health, US Department of Defense.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nephrology, University of Washington, Seattle, Washington, USA; Institute for Stem Cell & Regenerative Medicine, University of Washington, Seattle, Washington, USA. Electronic address: stuartjs@uw.edu.
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
- Department of Cardiovascular & Metabolic Sciences, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA. Electronic address: wesselo@ccf.org.
Förderung
- NIDDK NIH HHS
- National Institutes of Health
- US Department of Defense
Zitieren
APA
Shankland, S. J., Najafian, B., & Wessely, O. (2024). The tragedy of mitotic catastrophe in podocytes. Kidney International, 105(6), 1153-1156. https://doi.org/10.1016/j.kint.2024.01.015
Vancouver
Shankland SJ, Najafian B, Wessely O. The tragedy of mitotic catastrophe in podocytes. Kidney International. 2024;105(6):1153-1156. doi:10.1016/j.kint.2024.01.015
BibTeX
@article{Shankland2024,
author = {Shankland, Stuart J and Najafian, Behzad and Wessely, Oliver},
title = {The tragedy of mitotic catastrophe in podocytes},
journal = {Kidney International},
year = {2024},
volume = {105},
number = {6},
pages = {1153--1156},
doi = {10.1016/j.kint.2024.01.015}
}
EUVIMED